The present review aims to provide a comprehensive summary of the latest advancement in the study of NBCn1, focusing on the fundamental characteristics, regulation, and tissue-specific physiology as well as the development and application of potent inhibitors of NBCn1 transporter in cancer treatment. The gene discussed is SLC4A7; the disease is cancer.